NEW YORK (GenomeWeb News) – Cell Biosciences said today that it has acquired sample-prep company Protein Forest in an all-stock transaction worth an undisclosed amount.

In addition, Cell Biosciences said that in connection with the acquisition, it has raised an additional $4 million in equity financing, led by Novo A/S.

The acquisition adds Protein Forest's digital ProteomeChip product, including instrumentation, software, reagents, and consumables, to Santa Clara, Calif.-based Cell Biosciences' portfolio of protein-analysis products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.